394 related articles for article (PubMed ID: 8058523)
1. Soy intake and cancer risk: a review of the in vitro and in vivo data.
Messina MJ; Persky V; Setchell KD; Barnes S
Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
[TBL] [Abstract][Full Text] [Related]
2. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
3. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.
Messina M; Hilakivi-Clarke L
Nutr Cancer; 2009; 61(6):792-8. PubMed ID: 20155618
[TBL] [Abstract][Full Text] [Related]
4. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
5. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells.
Peterson G; Barnes S
Cell Growth Differ; 1996 Oct; 7(10):1345-51. PubMed ID: 8891338
[TBL] [Abstract][Full Text] [Related]
6. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
7. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
8. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.
Taylor CK; Levy RM; Elliott JC; Burnett BP
Nutr Rev; 2009 Jul; 67(7):398-415. PubMed ID: 19566600
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavone genistein in prevention and treatment of prostate cancer.
Perabo FG; Von Löw EC; Ellinger J; von Rücker A; Müller SC; Bastian PJ
Prostate Cancer Prostatic Dis; 2008; 11(1):6-12. PubMed ID: 17923857
[TBL] [Abstract][Full Text] [Related]
10. Quantification of genistein and genistin in soybeans and soybean products.
Fukutake M; Takahashi M; Ishida K; Kawamura H; Sugimura T; Wakabayashi K
Food Chem Toxicol; 1996 May; 34(5):457-61. PubMed ID: 8655094
[TBL] [Abstract][Full Text] [Related]
11. Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.
Messina M; Bennink M
Baillieres Clin Endocrinol Metab; 1998 Dec; 12(4):707-28. PubMed ID: 10384821
[TBL] [Abstract][Full Text] [Related]
12. Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways.
Valachovicova T; Slivova V; Bergman H; Shuherk J; Sliva D
Int J Oncol; 2004 Nov; 25(5):1389-95. PubMed ID: 15492830
[TBL] [Abstract][Full Text] [Related]
13. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
[TBL] [Abstract][Full Text] [Related]
14. Soy, isoflavones, and prostate cancer.
Jian L
Mol Nutr Food Res; 2009 Feb; 53(2):217-26. PubMed ID: 18985655
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
16. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of dietary isoflavones for cancer.
Andres S; Abraham K; Appel KE; Lampen A
Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720
[TBL] [Abstract][Full Text] [Related]
18. Early life and adult exposure to isoflavones and breast cancer risk.
Tomar RS; Shiao R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):113-73. PubMed ID: 18569328
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones.
Constantinou AI; Mehta RG; Vaughan A
Anticancer Res; 1996; 16(6A):3293-8. PubMed ID: 9042303
[TBL] [Abstract][Full Text] [Related]
20. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
